Abstract
Surgical resection is the primary treatment for early-stage non-small cell lung cancer (NSCLC). While open thoracotomy is the most frequently performed approach for lobectomy, minimally invasive surgical resection is a safe and viable alternative. Thoracoscopic lobectomy, also termed video-assisted thoracoscopic surgery lobectomy, is defined as the anatomic resection of an entire lobe of the lung—including mediastinal lymph node dissection—using a thoracoscope and an access incision without using a mechanical retractor and spreading of the ribs. As the procedure has evolved and been studied, thoracoscopic lobectomy has been demonstrated to be a safe and oncologically effective strategy in the surgical management of patients with stage I or II NSCLC, as well as selected patients with stage III NSCLC after induction therapy. Advantages of this approach include less postoperative pain, shorter chest tube duration and subsequent length of stay, fewer overall complications, better compliance with adjuvant chemotherapy, faster return to full activity, and greater preservation of pulmonary function.
Similar content being viewed by others
References and Recommended Reading
Ettinger DS, Bepler G, Bueno R, et al.; National Comprehensive Cancer Network (NCCN): Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006, 4:548–582.
Boffa DJ, Allen MS, Grab JD, et al.: Data from the Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 2008, 135:247–254.
Onaitis M, D’Amico TA: Minimally invasive management of lung cancer. In Sabiston and Spencer’s Surgery of the Chest. Philadelphia: Elsevier Science; 2004.
Burfeind WR, D’Amico TA: Thoracoscopic lobectomy. Oper Tech Thorac Cardiovasc Surg 2004, 9:98–114.
Onaitis MA, Petersen RP, Balderson SS, et al.: Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg 2006, 244:420–425.
Demmy TL, Curtis JJ: Minimally invasive lobectomy directed toward frail and high-risk patients: a case control study. Ann Thorac Surg 1999, 68:194–200.
Swanson SJ, Herndon J, D’Amico TA, et al.: Results of CALGB 39802: feasibility of VATS lobectomy for lung cancer [abstract]. Proc Am Soc Clin Oncol 2002, 21:290.
Daniels LJ, Balderson SS, Onaitis MA, et al.: Thoracoscopic lobectomy: a safe and effective strategy for patients with stage I lung cancer. Ann Thorac Surg 2002, 74:860–864.
Allen MS, Darling GE, Pechet TV, et al.: Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006, 81:1013–1020.
Sugi K, Yoshikazu K, Esado K, et al.: Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J Surg 2000, 24:27–31.
Walker WS, Codispoti M, Soon SY, et al.: Long-term outcomes following VATS lobectomy for non-small cell bronchogenic carcinoma. Eur J Cardiothorac Surg 2003, 23:397–402.
Roviaro G, Varoli F, Vergani C, et al.: Long-term survival after videothoracoscopic lobectomy for stage I lung cancer. Chest 2004, 126:725–732.
McKenna RJ, Houck W, Fuller CB: Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann Thorac Surg 2006, 81:421–426.
Petersen RP, Pham DK, Toloza EM, et al.: Thoracoscopic lobectomy: a safe and effective strategy for patients receiving induction therapy for non-small cell lung cancer. Ann Thorac Surg 2006, 82:214–218.
Arriagada R, Bergman B, Dunant A, et al.: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004, 350:351–360.
Winton TL, Livingston R, Johnson D, et al.: Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 2005, 352:2589–2597.
Petersen RP: Thoracoscopic lobectomy facilitates the delivery of adjuvant chemotherapy after resection for non-small cell lung cancer. Ann Thorac Surg 2007, 83:1245–1250.
Bonadonna G, Valagussa P, Moliterni A, et al.: Adjuvant cyclophosphamide, methotrexate, and fluorouracil in nodepositive breast cancer: the results of 20 years of follow-up. N Engl J Med 1995, 332:901–926.
D’Amico TA: Thoracoscopic lobectomy: evolving and improving. J Thorac Cardiovasc Surg 2006, 132:464–465.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Balderson, S.S., D’Amico, T.A. Thoracoscopic lobectomy for the management of non-small cell lung cancer. Curr Oncol Rep 10, 283–286 (2008). https://doi.org/10.1007/s11912-008-0044-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11912-008-0044-5